Frameless Stereotactic Radiosurgery for Brain Metastases
- Conditions
- Brain Metastases
- Interventions
- Device: Frameless Stereotactic Radiosurgery with radiation mask
- Registration Number
- NCT01476878
- Lead Sponsor
- Alberta Health services
- Brief Summary
The investigators plan to study high dose, single treatment radiation, using a plastic mask instead of a head frame that pins into a patient's skull. The investigators need to (1) quantify set-up accuracy and patient motion during radiation treatment and (2) ensure that without the head frame the tumour control rate and risk of complications are similar to our previous experience using the head frame.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
- Patients with brain metastases from a biopsy-proven primary extra-cranial tumor site, excluding lymphoma, germ cell, and small cell lung carcinoma histologies.
- One to four metastases, and all lesions < 3.5 cm in maximal diameter. Extracranial metastases is of minimal volume or stable with treatment. - Karnofsky performance status ≥ 70
-
None of the lesions is abutting or within critical neurological structures: *brainstem
- optic chiasm
- eye, and optic nerve.
-
The clearance between metastatic lesions and all critical structures must be at least 2 mm.
-
Patients must not have leptomeningeal disease.
-
Contraindications to imaging or radiation (e.g. pregnancy, elevated serum creatinine, allergy to contrast agents, severe claustrophobia, metal particles in the eye).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Open Arm Frameless Stereotactic Radiosurgery with radiation mask Each study patient will receive high dose, single treatment radiation using a plastic mask instead of a head frame that pins into a patient's skull.
- Primary Outcome Measures
Name Time Method Quantification of patient movement occurring during treatment. overall
- Secondary Outcome Measures
Name Time Method Local tumour control overall risk of complication (radionecrosis) overall
Trial Locations
- Locations (1)
Tom Baker Cancer Centre
🇨🇦Calgary, Alberta, Canada